Jeff Ajer

Director/Board Member at NEKTAR THERAPEUTICS

Net worth: 166 247 $ as of 31/10/2026

63 year

Health Technology

Consumer Services

Profile

Jeffrey Robert Ajer is currently an Independent Director at Nektar Therapeutics since 2017 and an Independent Director at Viridian Therapeutics, Inc. starting in 2025.
Former positions include Director-Purchasing Worldwide at Bausch Health Americas, Inc. from 1986 to 1999; Senior Director-Sales Operations, Bids & Contracts at SangStat Medical Corp.; Independent Director at True North Therapeutics, Inc.; Chief Commercial Officer & Senior Vice President at BioMarin Pharmaceutical, Inc. from 2012 to 2014; Vice President-Global Transplant Operations at Genzyme Corp.
from 2003 to 2005; and Chief Commercial Officer & Executive Vice President at BioMarin Pharmaceutical, Inc. from 2013 to 2024.
Education includes undergraduate and MBA degrees from the University of California, Irvine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NEKTAR THERAPEUTICS 0.01%	23/09/2026	4,277 ( 0.01% )	166 247 $	31/10/2026
VIRIDIAN THERAPEUTICS, INC. -.--%	01/07/2026	0 ( -.--% )	- $	31/10/2026

Jeff Ajer active positions

Companies	Position	Start
NEKTAR THERAPEUTICS	Director/Board Member	21/09/2017
VIRIDIAN THERAPEUTICS, INC.	Director/Board Member	27/03/2025

All active positions of Jeff Ajer

Former positions of Jeff Ajer

Companies	Position	End
BIOMARIN PHARMACEUTICAL INC.	Corporate Officer/Principal	20/05/2024
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Corporate Officer/Principal	01/08/2005
SangStat Medical Corp. SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation	Sales & Marketing	01/01/2003
Bausch Health Americas, Inc. Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals	Corporate Officer/Principal	01/07/1999
BIOMARIN PHARMACEUTICAL INC.	Corporate Officer/Principal	-

See the detail of Jeff Ajer's experience

Education of Jeff Ajer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeff Ajer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Bausch Health Americas, Inc. Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals	Health Technology
SangStat Medical Corp. SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation	Health Technology
Nektar Therapeutics Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need	Health Technology
BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions	Health Technology
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
University of California, Irvine University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
True North Therapeutics, Inc. True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases	Health Technology
Viridian Therapeutics, Inc. Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products	Health Technology